SCHEMBL31510934

SCHEMBL31510934

C[C@H]1C[C@@H](C(=O)ON2C(=O)c3ccccc3C2=O)N(C(=O)OC(C)(C)C)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ HTRA1 Q92743 1/20 0.37
▸ HSD11B1 P28845 1/20 0.36
▸ UCHL1 P09936 2/20 0.35
▸ NR1H2 P55055 2/20 0.34
▸ NR1H3 Q13133 1/20 0.34
▸ PARP1 P09874 1/20 0.34
▸ BRD4 O60885 1/20 0.34
▸ CREBBP Q92793 1/20 0.34
▸ EPHX2 P34913 1/20 0.33
▸ GPR119 Q8TDV5 1/20 0.33
▸ AR P10275 1/20 0.33
▸ PDK4 Q16654 1/20 0.33
▸ MCL1 Q07820 4/20 0.33
▸ SMARCA2 P51531 1/20 0.33
▸ SMARCA4 P51532 1/20 0.33
▸ PBRM1 Q86U86 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21637229 0.88 HSD11B1 (0.38) CYP1A2POLBCYP3A4CYP2C19HTRA1
SCHEMBL21765940 0.88 HSD11B1 (0.38) CYP1A2POLBCYP3A4CYP2C19HTRA1
SCHEMBL23975412 0.87 UCHL1 (0.44) POLBUCHL1EPHX2USP30
SCHEMBL22715472 0.82 EPHX2 (0.43) UCHL1NR1H2NR1H3EPHX2GPR119
SCHEMBL26985052 0.81 PTPN1 (0.39) UCHL1EPHX2GPR119PDK4
SCHEMBL30954452 0.81 UCHL1 (0.39) POLBUCHL1NR1H2NR1H3PARP1
SCHEMBL30537463 0.81 EPHX2 (0.51) POLBHSD11B1UCHL1EPHX2USP30
SCHEMBL31510905 0.81 EPHX2 (0.51) POLBHSD11B1UCHL1EPHX2USP30
SCHEMBL28459867 0.81 EPHX2 (0.51) POLBHSD11B1UCHL1EPHX2USP30
SCHEMBL31511192 0.80 EPHX2 (0.48) POLBHSD11B1UCHL1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250276966-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives PFIZER (US) 2025-09-04 — — US disclosed
US-20250122183-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives PFIZER (US) 2025-04-17 — — US disclosed
WO-2025074249-A1 NITROGEN-LINKED BENZISOXAZOLE SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF CANCER PFIZER INC. (US) 2025-04-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122183-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives CCNI, MKI67, CCNA1 CYP1A2 723/4885POLB 3308/4885CYP3A4 566/4885
US-20250276966-A1 Nitrogen-Linked Benzisoxazole Sulfonamide Derivatives CCNI, MKI67, CCNA1 CYP1A2 732/4885POLB 3358/4885CYP3A4 601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback